Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Patient preparation, positioning and immobilisation
9000
Poster (digital)
RTT
Assessing the inter and intra-fraction changes utilising MR Linac for cervical cancer
Amerah Alshamrani, United Kingdom
PO-1853

Abstract

Assessing the inter and intra-fraction changes utilising MR Linac for cervical cancer
Authors:

Amerah Alshamrani1, Robert Chuter2, Claire Nelder3, Ananya Choudhury4, Lisa Barraclough5, Cynthia Eccles6, Marianne Aznar6, Peter Hoskin7

1The University of Manchester, Faculty of Biology, Medicine and Health, MANCHESTER, United Kingdom; 2Christie NHS Foundation Trust, Clinical Oncology, MANCHESTER, United Kingdom; 3Christie NHS Foundation Trust, Radiotherapy, Manchester, United Kingdom; 4Christie NHS Foundation Trust, Clinical Oncology, MANCHESTER, United Kingdom; 5Christie NHS Foundation Trust, Clinical Oncology, MANCHESTER, United Kingdom; 6The University of Manchester, Faculty of Biology, Medicine and Health, MANCHESTER, United Kingdom; 7The Christie NHS Foundation Trust, Clinical Oncology , MANCHESTER, United Kingdom

Show Affiliations
Purpose or Objective

Online adaptive radiotherapy based on MR Linac (MRL) can potentially address inter and intra-fractional changes using images acquired daily during treatment. We report the intra- and inter-fractional movement for the first 25 fraction cervical cancer treatment delivered on the MRL in the UK. 

Material and Methods

Following institutional approval, a woman with stage FIGO-IIB node-negative cervical cancer was consented to the MOMENTUM trial (NCT04075305) for 25 fractions of radiotherapy. Treatment was prescribed according to the EMBRACE II guidelines using adapt-to-shape (ATS) workflow. A comfortably full bladder was required for treatment.  

Three MRIs were acquired at each fraction: a setup image ( used for plan adaptation), a verification (verif) image (acquired immediately prior to ‘beam on’) and a post-treatment (post-treat) image (to assess intra-fractional changes). A single observer contoured the bladder and CTV on all available verif and post-treat MRIs. Intra-fraction changes in bladder and CTV were determined by measuring the volume differences between the setup and verif images and the volume differences between the verif and post-treat images. The inter-fraction changes in CTV and bladder volumes were determined by measuring the difference between the verif images from each fraction and the MRI used for initial treatment planning.  Intra-fractional changes were reported using Dice coefficients (DC) and inter-fraction changes reported using volume changes in cm3. Statistics have been presented as descriptive statistics and boxplots.

Results

22 fractions and 67 MR images were available for review.  The mean treatment time was 68 min (range 51–82 min) from the time the patient entered the room until the patient left. The median time from the setup image to verif image was 43.5 min (range 31-72 min). The median time from verif image to post-treat image was 13 min (range 4-40 min). The median intra-fraction DC for the CTV was 0.62 (range 0.40-0.80) and 0.90 (range 0.57-0.95) for the setup to verif and verif to post-treat images respectively. The median intra-fractional DC in bladder volume from setup to verif images and from verif to post-treat images were 0.67 (range 0.44-0.83) and 0.90 (range 0.54-0.97) respectively. Figure 1 shows the intra-fraction variation from setup to verif and verif to post treat images for both bladder and CTV. CTV volume changes were greatest in the adaption time, and smaller during radiation delivery. For inter-fraction movement, median volume for CTV and bladder were 7.41cm3 (range -4.30-24.92) and -133cm3 (range-382.63-57), respectively. No consistent bladder or CTV volume patterns were observe.



Conclusion

Drinking protocols were not optimal to keep bladder volume constant. The low DC value justifies the need for an ATS workflow. Real-time adaptation based on MRL addressed inter and intra-fraction CTV and bladder changes by allowing an online correction that improves delineation and treats on the most updated plan.